Pilot study: Non-interventional study to observe and document the use of KadeZyklus(R) bei Krämpfen während der Menstruation in gynaecological practice with regard to the perceived change in cramps during menstruation and tolerability of the treatment. - KANO

DR. KADE Pharmazeutische Fabrik GmbH0 个研究点目标入组 25 人开始时间: 2023年1月5日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•The patient has been informed about the study and has signed the informed consent form.
•The patient is at least 18 years old.
•Female gender (from birth).
•The patient suffers from primary dysmenorrhoea without organic causes with mild cramps during menstruation.
•The decision to use KadeZyklus bei Krämpfen was made independently and prior to inclusion in this NIS.
•The patient is currently planning to use KadeZyklus bei Krämpfen during her next two cycles according to the professional information / instructions for use.
•The patient agrees to keep the diary for the next two cycles and to hand it over or return it to the doctor.
•The patient suffered from mild cramps on at least 2 days in each of the last 3 cycles.

•The patient has had irregular menstrual cycles for the last 3 months.
•The patient suffers from secondary dysmenorrhoea (painful menstruation of organic origin, endometriosis, fibroids, inflammatory changes).
•The patient has a known hypersensitivity to the active substance in KadeZyklus bei Krämpfen während der Menstruation, to other compositae or to any of the other ingredients listed in the product information.
•The patient is pregnant or breastfeeding
•The patient is participating in a parallel clinical trial during the study.

发起方